baber/WOPTO huggingface dataset:
Patent CY-1107287-T1 (CY)
Title: Χρηση της ερυθροποιητινης, καθως και παραγωγων αυτης για τη θεραπεια σχιζοφρενειων και συναφων ψυχωσεων
Inventor: EHRENREICH HANNELORE
IPC: A61K38/22
Filed: 2008-02-21
Abstract: Μέθοδος για τη θεραπεία και/ή την προφύλαξη από τη σχιζοφρένεια και συναφείς ψυχώσεις ενός θηλαστικού, όπου η ερυθροποιητίνη χορηγείται στο θηλαστικό.
Patent CY-1108732-T1 (CY)
Inventor: KUEHN TORSTEN
IPC: A61K9/48
Filed: 2009-01-14
Abstract: The present invention relates to capsules for housing pharmaceutical preparations for powder inhalers with increased medicinal product safety and capsules for pharmaceutical preparations for powder inhalers with improved adaption to use in powder inhalers. The capsules consist of non-water-soluble, hydrophobic plastics, which themselves do not substantially influence the pharmaceutical quality of the contents, but improve the usability of the filled capsules in respect of their operation, the period of use and/or the geographical location of their use and are advantageous in various steps from manufacture to use.
Patent CY-1108726-T1 (CY)
Title: Ακροφυσιο ποτισματος πολλαπλης δεσμης με αντιθετα περιστρεφομενα στοιχεια δια αναδυομενο εκ του εδαφους εκτοξευτηρα
Inventor: ROMAN GIANFRANCO
IPC: B05B3/04
Filed: 2009-01-27
Abstract: Ένα ακροφύσιο ποτίσματος (16) δια έναν αναδυόμενο εκ του εδάφους εκτοξευτήρα (1) περιλαμβάνει ένα κάτω μέρος (17) και ένα άνω μέρος (37), το οποίον περιλαμβάνει έναν κύλινδρο διανομής (40). Το κάτω μέρος (17) είναι εφοδιασμένο με ένα δακτυλιοειδές άνοιγμα (100), το οποίο λαμβάνει το ρεύμα του ύδατος, το οποίον προέρχεται από τη βάση του εκτοξευτήρα (1) και δημιουργεί μια δέσμη υπό τη μορφή ενός ψεκάσματος που έχει προκαθορισμένη γωνιακή έκταση και ρέει εντός ενός κυλίνδρου διανομής (40) εφοδιασμένου με ακτινικές σχισμές (41) διατεταγμένες υπό μορφήν τόξου περιφερείας εκτεινομένου από το κάτω μέρος προς το πλάγιο τοίχωμα του, ώστε να υποδιαιρεί τη μοναδική δέσμη ψεκάσματος σε μεμονωμένες δέσμες. Ο κύλινδρος διανομής (40) περιστρέφεται υπό την επίδραση της μοναδικής δέσμης ύδατος επί των τοιχωμάτων των αναφερθεισών ακτινικών σχισμών και μέσω ενός συνόλου γραναζιών (200) ο τροχός ανεμιστήρος (70) περιστρέφεται με αντίθετη φορά ως προς τον κύλινδρο (40) κατά τρόπον ώστε οι διάφορες δέσμες ύδατος που εξέρχονται από τις σχισμές (41) να υποδιαιρούνται κατά ακτινική διεύθυνση.
Patent CY-1109746-T1 (CY)
Inventor: BOZZONI I
IPC: A61K38/00
Filed: 2010-02-03
Abstract: A gene is described that encodes for a snRNA modified such that it contains an antisense sequence complementary to at least one of the two splice junctions at 5' and/or 3' of one of the exons encoding for a protein of therapeutic interest, whose sequence should be skipped during the splicing process that converts the pre-mRNA to the mature mRNA. The gene is particularly advantageous which it contain segments complementary to both splice junctions. If introduced into appropriate vectors, the gene is useful in gene therapy, particularly in the treatment of Duchenne Muscular Dystrophies. dystrophic diseases.
Patent CY-1111094-T1 (CY)
Inventor: LOBL THOMAS J
IPC: A61P35/00
Filed: 2010-06-10
Abstract: The compound of the invention is a prodrug form of a therapeutic agent linked directly or indirectly to an oligopeptide, which in turn, is linked to a stabilizing group. More generally, the present invention may be described as a new prodrug compound of a therapeutic agent, especially prodrugs comprising an antitumor therapeutic agent, displaying improved therapeutic properties relative to the products of the prior art, especially improved therapeutic properties in the treatment of cancerous tumors and/or in the treatment of inflammatory reactions such as rheumatic diseases. Improved therapeutic properties include decreased toxicity and increased efficacy. Particularly desired are prodrugs which display a high specificity of action, a reduced toxicity, an improved stability in the serum and blood, and which do not move into target cells until activated by a target cell associated enzyme. Prodrug compounds of a marker enabling tumors to be characterized (diagnosis, progression of the tumor, assay of the factors secreted by tumor cells, etc.) are also contemplated. The present invention also relates to the pharmaceutical composition comprising the compound according to the invention and optionally a pharmaceutically acceptable adjuvant or vehicle. Further, a method of decreasing toxicity by modifying a therapeutic agent to create a prodrug is disclosed. Several processes for creating a prodrug of the invention are described. Compounds of the invention include the prodrugs, Suc-ssAla-Leu-Ala-Leu-Dox, Suc-ssAla-Leu-Ala-Leu-Dnr, and Glutaryl-ssAla-Leu-Ala-Leu-Dox. Additionally intermediate compounds, important to the process of preparation of the prodrugs of the invention are claimed.
Patent CY-1116604-T1 (CY)
Title: Προγραμματιζομενη κλειδαρια κυλινδρου εχουσα μεγαλον αριθμο συνδυασμων
Inventor: LORETI ALBERTO
IPC: E05B27/10
Filed: 2015-08-13
Abstract: Μία προγραμματιζόμενη κλειδαριά κυλίνδρου του τύπου που περιλαμβάνει έναν στάτορα και έναν κυλινδρικό στροφέα 2, εγκατεστημένον εσωτερικά του στάτορα γιά περιστροφή περί τον άξονα του και έχοντα μία οπή κλειδιού για εισαγωγή ενός κλειδιού 3, και περιλαμβάνουσα εσωτερικά του στροφέα έναν αριθμό ακολουθητών κλειδιού 4 κινητών κατά μήκος της διαμήκους και της εγκάρσιας κατεύθυνσης τους, που αποσκοπούν να συνεργάζονται με ένα κλειδί 3 εισαγόμενο εντός της οπής κλειδιού του στροφέα 2, και έναν αριθμό ασφαλιστικών πείρων 6 κινητών κατά την διαμήκη διεύθυνση τους, με τους ακολουθητές κλειδιού 4 και τους ασφαλιστικούς πείρους 6 να σχηματίζουν μαζί έναν αριθμό ζευγών και έχοντες οδοντώσεις που αποσκοπούν στο να συνεργάζονται προκειμένου να ορίζουν την κωδικοποίηση της κλειδαριάς, με τον στροφέα 2 να περιλαμβάνει μία ράβδο τερματισμού 9 συνεργαζόμενη με μία διαμήκη αυλάκωση 10 του στάτορα και που έχει προεξοχές επιδεκτικές συνεργασίας με εντομές των ασφαλιστικών πείρων 6 προκειμένου να ακινητοποιούν τους ασφαλιστικούς πείρους 6 όταν η ράβδος τερματισμού 9 εμπλέκεται με τους ασφαλιστικούς πείρους 6, και που περιλαμβάνουν μία ράβδο αλλαγής 11 η οποία συζευγνύεται ολισθητικά με τους ακολουθητές κλειδιού 4 προκειμένου να διατηρούνται φυσιολογικά οι ακολουθητές κλειδιού 4 σε εμπλοκή με τους ασφαλιστικούς πείρους 6 και να απεμπλέκουν τους ακολουθητές κλειδιού 4 από τους ασφαλιστικούς πείρους 6 όταν η ράβδος αλλαγής 11 προσφέρει μία θέση προγραμματισμού κλειδαριάς, χαρακτηριζόμενη από το ότι ένα των μελών 4, 6 το οποίο συνθέτει ένα ζεύγος προσφέρεται με δύο παράλληλες και γειτονικές οδοντώσεις 7a, 7b, με κάθε οδόντωση 7a, 7b να έχει μετατοπισμένη την φάση του βήματος της
Patent CY-1119129-T1 (CY)
Title: Ανυδρη κρυσταλλικη μορφη της διμεθοξυ ντοσεταξελης και οι διαδικασιες παρασκευης της
Inventor: BILLOT PASCAL
IPC: C07D305/14
Filed: 2016-12-07
Abstract: Άνυδρα αιθανολικά διαλυτώματα και ετερο-διαλυτώματα, υδριτές διμεθοξυ ντοσεταξέλης ή (2R,3S)-3-τριτ-βουτοξυκαρβονυλαμινο-2-υδροξυ-3-φαινυλ-προπιονικού 4-ακετοξυ-2α-βενζοϋλοξυ-5β,20-εποξυ-1-υδροξυ,7β, 10β-διμεθοξυ-9-οξο-ταξ-11-εν-13α-υλίου και η παρασκευή τους.
Patent CY-1119334-T1 (CY)
Inventor: MATTHEWS FRANK
IPC: A61K9/50
Filed: 2017-07-24
Abstract: Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided.
Patent CY-1121083-T1 (CY)
Title: Αντιμικροβιακο πεπτιδιο και οι χρησεις αυτου
Inventor: NIBBERING PETRUS HENDRICUS
IPC: C07K14/47
Filed: 2018-10-18
Abstract: Η εφεύρεση αναφέρεται σε αντιμικροβιακά πεπτίδια, στις φαρμακευτικές συνθέσεις που περιλαμβάνουν τα εν λόγω πεπτίδια και στις χρήσεις αυτών για τη θεραπεία ή την πρόληψη μικροβιακής, βακτηριακής, μυκητιακής, ιικής και παρασιτικής λοίμωξης.
Patent CY-1122806-T1 (CY)
Title: Μεθοδοι αγωγης της ηπατικης εγκεφαλοπαθειας
Inventor: FORBES WILLIAM
IPC: A61K31/395
Filed: 2020-02-21
Abstract: Η αίτηση περιγράφει την αγωγή ηπατικής εγκεφαλοπάθειας με τη χρήση ενός ειδικού γαστρεντερικού αντιβιοτικού. Ένα παράδειγμα ενός ειδικού γαστρεντερικού αντιβιοτικού είναι η ριφαξιμίνη.
Patent CY-1123056-T1 (CY)
Title: Νεα μορφη χορηγησης της ρασεκαδοτριλης
Inventor: JULIEN JEAN-STÉPHANE
IPC: A61K31/216
Filed: 2020-04-24
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ένα νέο σκεύασμα ενός αναστολέα της εγκεφαλινάσης, όπως ρασεκαδοτρίλης ή δεξεκαδοτρίλης, στη διεργασία παρασκευής αυτού, και στη χρήση αυτού για την αγωγή της διάρροιας.
Patent CY-1122925-T1 (CY)
Title: Συνθεσεις και μεθοδοι για ανοσορρυθμιση σε εναν οργανισμο
Inventor: LEFRANCOIS LEO
IPC: C07K1/00
Filed: 2020-05-13
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ένα θεραπευτικό πολυπεπτίδιο και μεθόδους για τη δημιουργία και χρήση αυτού για τη διαμόρφωση μιας ανοσολογικής απόκρισης σε έναν οργανισμό ξενιστή που τη χρειάζεται. Ειδικότερα, η εφεύρεση αναφέρεται στη χορήγηση σε έναν οργανισμό που χρήζει αυτής, μιας αποτελεσματικής ποσότητας ενός προ-συζευγμένου πολυπεπτιδικού συμπλόκου που αποτελείται από ένα σύμπλοκο αποτελούμενο από ένα τμήμα πολυπεπτιδίου λεμφοκίνης, για παράδειγμα IL-15 (SEQ ID NO: 5, 6), lL-2 (SEQ ID NO: 10, 12) ή συνδυασμούς και των δυο, και ένα τμήμα πολυπεπτιδίου υποδοχέα ιντερλευκίνης, για παράδειγμα IL- 15Ra (SEQ ID NO: 7, 8), IL-2Ra (SEQ ID NO: 9, 11) ή συνδυασμούς και των δυο, για την αύξηση του ανοσοποιητικού συστήματος, για παράδειγμα, σε καρκίνο, SCID, AIDS, ή εμβολιασμό, ή αναστολή του ανοσοποιητικού συστήματος, για παράδειγμα, σε ρευματοειδή αρθρίτιδα, ή Λύκο. Το θεραπευτικό σύμπλοκο της εφεύρεσης καταδεικνύει απροσδόκητα αυξημένη ημίσεια ζωή, και αποτελεσματικότητα in vivo.
Patent CY-1122977-T1 (CY)
Title: Διαμορφωση στηθαιου με στυλους αγκιστρωσης
Inventor: LASS HERR HORST
IPC: E01F15/04
Filed: 2020-06-02
Abstract: Η παρούσα εφεύρεση αφορά διαμόρφωση στηθαίου 1, πιο συγκεκριμένα χρησιμοποιούμενη ως σύστημα συγκράτησης οχημάτων σε οδόστρωμα, όπου τουλάχιστον μία δέσμη στηθαίων 2 αποτελούμενη από στηθαία τοποθετημένα εν σειρά σε επαφή το ένα με το άλλο είναι χωροδιατεταγμένη σε ορισμένη κατακόρυφη απόσταση από επιφάνεια 6 ενός υποβάθρου 7 και είναι στερεωμένη σε στύλους 5, η οποία χαρακτηρίζεται από το ότι οι στύλοι 5 είναι ανεπτυγμένοι κατά την κατακόρυφη διεύθυνση V ως διμερείς αποτελούμενοι από έναν στύλο αγκίστρωσης 9 εισαγμένο στο υπόβαθρο 7 και έναν συζευγμένο με αυτόν στύλο κράτησης 8.
Patent HR-P20100066-T1 (HR)
Title: Antagonist anti-cd40 monoclonal antibodies and methods for their use
Inventor: LONG LI
IPC: A61K39/395
Filed: 2010-02-03
Abstract: Methods of treating a subject for a cancer comprising neoplastic cells expressing the CD40 cell surface antigen are provided. The methods comprise combination therapy with interleukin-2 (IL-2) or biologically active variant thereof and at least one antagonist anti-CD40 antibody or antigen-binding fragment thereof. In some embodiments, these two therapeutic agents are concurrently administered as two separate pharmaceutical compositions, one containing IL-2 or biologically active variant thereof, which is administered according to a constant IL-2 dosing regimen or a two-level IL-2 dosing regimen, the other containing the antagonist anti-CD40 antibody or suitable antigen binding fragment thereof, which is administered according to a weekly dosing regimen, or alternatively is dosed once every two, three, or four weeks.; Administering of these two agents together potentiates their effectiveness in promoting a positive therapeutic response. The methods find use in treating CD40-expressing cancers, including B-cell related cancers and solid tumors.
Patent HR-P20110915-T1 (HR)
Inventor: PEGLION JEAN-LOUIS
IPC: C07D223/16
Filed: 2011-12-06
Abstract: Postupak za sintezu spoja formule (VII) u racemički ili optički aktivnom obliku: pri čemu R predstavlja vodikov atom ili metilnu skupinu, naznačen time, da je spoj formule (VIII): reagirao sa spojem formule (IX), u racemički ili optički aktivnom obliku, u obliku slobodne lužine ili soli: gdje je R kao što je gore definirano, u nazočnosti soli prijelaznog metala ili lantanida, u otapalu, kako bi se dobio spoj formule (X), u racemički ili optički aktivnom obliku: koji se djelovanjem agensa donora hidrida pretvorio u spoj formule (VII). Patent sadrži još 11 patentnih zahtjeva.
Patent SI-1465518-T1 (SI)
Inventor: GREY NICHOLAS GERALD
Filed: 2003-10-31
Abstract: A brush for a surface cleaning apparatus comprises a substantially cylindrical member provided with a plurality of tufts of bristles (118, 119, 121) extending substantially radially therefrom. The bristles are of first and second lengths, the first length (121) being longer than the second length (119). Bristles of both the first and second lengths are distributed substantially along the axial length of the substantially cylindrical member, whereby the bristles of the first length are adapted to reach down into irregularities in a surface (104) to be cleaned. <IMAGE>
Patent SI-1502587-T1 (SI)
Title: Sustained release formulation for Venlafaxine hydrochloride
Inventor: KARAVAS EVANGELOS
IPC: A61K31/00
Filed: 2003-07-30
Abstract: The invention provides a sustained release composition that;  1. Is free of initially increased drug delivery that occurs in sustained release systems containing the water soluble drug venlafaxine HCl, known as burst phenomenon, by using a functional core partially or totally coated by a functional coating layer or film. 2. Delivers the drug substance within 24 hours and is therefore suitable for once daily administration of the said drug substance. 3. Exhibits linearity between the strength of the drug formulation and the total mass of the formulation, by proportional increase of the amounts of the drug substance and the excipients in the formulation. 4. Is possible to be divided in smaller doses, without affecting the release of the drug substance.  <??>The invention provides a sustained release capsule formulation containing an appropriate number of functional complex mini tablets comprising of:  1. A functional core comprising the active ingredient, especially the water-soluble drug Venlafaxine HCl and appropriate excipients. 2. A functional coating layer or film that reduces the initial surface of the core that is available for the release of the water-soluble drug Venlafaxine HCl, reducing the burst phenomenon.
Patent SI-2190625-T1 (SI)
Title: Machine tool having two carriages and a tool magazine
Inventor: BENZ WINFRIED
IPC: B23Q1/25
Filed: 2008-08-07
Abstract: A machine tool has, on a machine bed, two stands which can be moved in the horizontal x- and z-direction, on which y-slides carrying tool spindles can be vertically moved. Arranged on one of the stands directly above a bridge projecting over its upper side is at least one tool magazine, with which a tool changer is associated for each stand. The drives for the y-slides are attached below the upper side of the stands to the stands.
Patent SI-2519454-T1 (SI)
Title: Packaged abrasive articles
Inventor: ZHANG HAN
IPC: B65D85/00
Filed: 2010-12-29
Abstract: An article includes a packaging material comprising a self-supporting wall having a water vapor transfer rate of not greater than 0.001 g/m2-day. The packaging material defines an enclosed volume. The article further includes a bonded abrasive article disposed within the enclosed volume. The bonded abrasive article includes abrasive grains dispersed in a polymer matrix. The polymer matrix includes hygroscopic material.
Patent TR-200003196-T1 (TR)
Inventor: PREVOT ROGER M
IPC: B65D1/02
Filed: 2000-02-29
Abstract: Hot-fillable, blow molded, wide-mouth plastic containers having a pair of flex panels (11, 111, 211) for accommodating thermally induced volumetric and pressure variations while affording easy contents scoopability, and desirable labeling features. The containers are capable of being blow-molded from injection molded preforms or from extruded parisons. The containers may be hot-filled and retorted. A desirable base (27, 127, 227) for a retortable container is also disclosed.
Patent TR-200003576-T1 (TR)
Title: İtme ve çıkma elips düğme  grubu
Inventor: KARAHASANOGLU ALP
IPC: H01H9/00
Filed: 1999-02-08
Abstract: Herhangi bir baglayici eleman kullanilmadan kam (4), ara parça (5), dügme (1) ve gösterge parçasi (2) üst üste takilarak dügme grubu olusturulmustur. Elips seklindeki dügmenin (1), itme ve çikma dügme mekanizmasindaki yük (8) kuvveti ile hareketi  ve ergonomik kullanim kolayligi saglanmis, bu dügme grubuna yönlendirici mekanizmayi kontrol eden kam (4) eklenmistir. Merkezleme tirnaklari (6) ile istenilen  yerde ara parça (5) ve kama (4) tutturulan elips dügme (1), yay (8) ve takip teli (7) sayesinde açik ve kapali pozisyon hareketini saglamaktadir.
Patent TR-201010642-T1 (TR)
Title: Yüksek öncelikli paketler için koruma sağlayan kablosuz yerel ağ cihazları
Inventor: TASKIN METIN ISMAIL
IPC: H04W28/24
Filed: 2008-06-19
Abstract: Bu buluş WLAN ağı içinde iletilen yüksek öncelikli paketlerin komşu WLAN ağlarda ve 802.1 İs örgü ağlannda rastlanan saklı istasyonlardan seçmeli RTS/CTS sinyalleşmesi mimarisinden faydalanılarak komnması ile servis kalitesi (QoS) artırmak ve paket kaybı oranını (PLR) düşürmek ile ilgilidir. Bu buluşta geliştirilen WLAN cihazları RTS sinyali gönderir ve yüksek öncelikli pkaetleri göndermeden önce CTS için bekler fakat düşük öncelikli diğer paketler için RTS göndermez. Yüksek öncelikli paketler çoğunlukla yüksek QoS ve düşük PLR gereksinimleri olan gerçek zamanlı teslim gerektiren görüntü ve ses paketleridir. Sadece yüksek öncelikli trafik için RTS/CTS sinyalleşmesini etkinleştirerek, RTS/CTS sinyalleşmesi ile ortaya çıkan toplam ek yük minimize edimiştir ve toplan ağ faydalı veri miktarı kapasitesi optimize edilmiştir. Bu cihazlar ayrıca ses ve görüntü ve buna benzer sinyalleri beton binalardaki kablosuz sinyal zayıflaması problemlerinin üstesinden gelebilmek için IEEE 802.11 s standardına uyumlu kablosuz örgü ağları oluşturarak yüksek kalitede transfer edebilirler. 802.1 İs örgü ağındaki her bir örgü noktası ayrıca örgü ağı boyunca yüksek öncelikli paketleri kommak için seçmeli RTS/CTS sinyalleşmesini uygularlar. Buluşu yapılan bu cihazlar aynı zamanda VoIP, IPTV veya DSL modem özelliklerini aynı donanım üzerinde 802.1 İg ve 802.1in gibi farklı 802.11 standardlarmdan faydalanacak şekilde entegre edilmiş olarak içerebilir.
Patent DE-3688204-T2 (DE)
Inventor: CARNEY WALTER PATRICK
IPC: C07K16/00
Filed: 1986-01-28
Granted: 1993-11-04
Abstract: A monoclonal antibody reactive with a peptide containing the amino acid sequence Lysine-Leucine-Valine-Valine-Valine-Glycine-Alanine-Valine-Glycine-Val ine-Glycin e-Lycine may be used in the diagnosis of primary and metastatic carcinomas. The antibody may be produced by culturing a suitable hybridoma.
Patent DE-3781588-T2 (DE)
Inventor: GASTALDELLO GIULIANO
IPC: A47B57/42
Filed: 1987-05-19
Granted: 1993-01-07
Abstract: The shelving unit comprises uprights (1) arranged in pairs following transverse alignments and produced in the form of hollow casings with a T-shaped cross-section. In the lateral openings (2) of square profile (2) of these uprights are engaged supports (6) which penetrate inside openings (10) made on the longitudinal sides of the shelves (7); the structure is rendered extremely stable by the presence of projecting fins (8) which bear on the inner wall of the uprights (1) while teeth (9) bear on the wall of the latter, rendering the structure very stable and facilitating assembly. <IMAGE>
Patent DE-3784607-T2 (DE)
Inventor: MOREAU HERVE
IPC: C12N9/20
Filed: 1987-09-04
Granted: 1993-10-07
Abstract: Rabbit or horse stomachs are subjected to an extraction with an acidic aqueous medium, the lipase extract is salted out by adding water-soluble salts and then an eluate fraction containing the lipase is collected by filtration on molecular sieve followed by a separation by ion exchange chromatography. Medication for combating malabsorptions of fatty substances.
Patent DE-3785232-T2 (DE)
Inventor: RISCO MICHAEL K
IPC: C07H15/14
Filed: 1987-01-30
Granted: 1993-09-09
Abstract: Methylthioribose analogues of formula (I) are new where (R= H, Cl, F, Br, I or R1S; R1 = 1-10C alkyl or halogenated alkyl; R2, R3, R4 = H or OH; with the proviso that at least one of R2, R3, R4 is OH and the further proviso that when R2, R3 and R4 are all OH, R1 is other than Me or i-butyl).
Patent DE-3785763-T2 (DE)
Inventor: WILKINS STEPHEN
IPC: H05G1/02
Filed: 1987-08-14
Granted: 1993-10-21
Abstract: PCT No. PCT/AU87/00262 Sec. 371 Date Mar. 20, 1989 Sec. 102(e) Date Mar. 20, 1989 PCT Filed Aug. 14, 1987 PCT Pub. No. WO88/01428 PCT Pub. Date Feb. 25, 1988.In one embodiment, an x-ray neutron instrument includes an x-ray or neutron lens (10) disposed in a path for x-rays or neutrons in the instrument. The lens (10) comprises multiple elongate open-ended channels (12) arranged across the path to receive and pass segments of an x-ray or neutron beam (14). The channels (12) have side walls reflective to x-rays or neutrons of the beam incident at a grazing angle less than the critical grazing angle for total external reflection of the x-rays or neutrons, whereby to cause substantial focusing or collimation and/or concentration of the thus reflected x-rays or neutrons. In a different embodiment, a condensing-collimating channel-cut monochromator comprises a channel (22) in a perfect-crystal or near perfect-crystal body (20). This channel (22) is formed with lateral surfaces (24, 26) which multiply reflect, by Bragg diffraction from selected Bragg planes, an incident beam (28) which has been collimated at least to some extent. The lateral surfaces (24, 26) are at a finite angle to each other whereby to monochromatize and spatially condense the beam (28) as it is multiply reflected, without substantial loss of reflectivity or transmitted power.
Patent DE-3879690-T2 (DE)
Inventor: BOGERS PETER CORNELIS LEONARD
IPC: C02F1/48
Filed: 1988-07-12
Granted: 1993-07-22
Abstract: Stainless steel sponge (1) for installation in a hot water reservoir in order to reduce scale deposits on the bottom or other parts of it. Said sponge (1) being made of stainless steel wire (2) having a rectangular cross section with a thickness (d) lying between 0.03 and 0.05 mm, and a width (b) amounting from 5 to 20 times the thickness (d). Said wire being made by rolling a round wire (6) between cylinders (7) and guiding the obtained flat wire (2) along a chisel edge (8) under tension force. Said sponge (1) being positioned as close as possible to the hottest place of the container.
Patent DE-3883096-T2 (DE)
Inventor: LIANG PAUL MING SAN
IPC: H01J29/89
Filed: 1988-06-21
Granted: 1993-12-02
Abstract: A protective screen (12) is formed of a frame (15) and a series of woven, non-metallic fibers (14). The screen (12) is fitted over the display surface of a cathode ray tube (10) to reduce glare and/or to diffuse emanated radiation and static electricity. The frame includes outer non-metallic frame parts and a rigidifying metallic inner frame part.
Patent DE-3883895-T2 (DE)
Inventor: BAKER CHRISTOPHER JOHN STANLEY
IPC: G01N27/00
Filed: 1988-08-09
Granted: 1994-03-24
Abstract: A disposable cartridge for use in a clinical sensing arrangement interfaces electrically with a host instrument capable of responding to electrical signals generated by detector devices (2) incorporated in the cartridge upon exposure to calibrant fluids and/or clinical fluids under examination. The cartridge includes a passage (3) linking a reservoir of calibrant fluid (4) to the detector devices and further linking said device to a closed container (5) for fluid which has been conveyed past the devices. A fluid under test can be introduced into the cartridge through the passage wall (7) at a location disposed between the reservoir and the detector devices.